Skip to Main Content Skip to Site Map Skip to Accessibility Statement

Altnagelvin Hospital

Trial CAPItello-292
Cancer Type Breast Cancer
Hospital(s) Altnagelvin Hospital
Information

A Phase Ib/III, Open-label, Randomised Study of Capivasertib plus CDK4/6 Inhibitors and Fulvestrant versus CDK4/6 Inhibitors and Fulvestrant in Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced, Unresectable or Metastatic Breast Cancer

Trial EndoNET
Cancer Type Breast Cancer
Hospital(s) Altnagelvin Hospital and Belfast City Hospital
Information

Randomised controlled trial evaluating effectiveness of neoadjuvant endocrine treatment in post-menopausal women

Trial MOSAICC
Cancer Type Haematological Cancers and Other Haematological
Hospital(s) Altnagelvin Hospital, Antrim Hospital, Belfast City Hospital, Craigavon Hospital, and Ulster Hospital
Information

MyeloprOliferative NeoplasmS An In-Depth Case-Control Study: A Case-Control Study Of Patients With Myeloproliferative Neoplasms And Non-Blood Relative/Friend Controls

Trial SMALL Trial
Cancer Type Breast Cancer
Hospital(s) Altnagelvin Hospital, Belfast City Hospital, and Craigavon Hospital
Information

A Phase III, randomised, multi-centre trial addressing overtreatment of small screen-detected breast cancer by comparing standard surgery versus minimally invasive vacuum-assisted excision

Trial TROPION - 03
Cancer Type Breast Cancer
Hospital(s) Altnagelvin Hospital
Information

A Phase 3 Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Versus Investigator’s Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Who Have Residual Invasive Disease in the Breast and/or Axillary Lymph Nodes at Surgical Resection Following Neoadjuvant Systemic Therapy (TROPION-Breast03)

Trial UKGPC
Cancer Type Genitourinary and Prostate Cancer
Hospital(s) Altnagelvin Hospital, Antrim Hospital, and Ulster Hospital
Information

UK Genetics Prostate Cancer Study

Click Here to view Cancer Research UK trial summary